Add Yahoo as a preferred source to see more of our stories on Google. The FDA on Aug. 5, 2026 approved a new mRNA-based flu vaccine. (Melissa Phillip/AP) After months of regulatory questioning, the ...

The vaccine, mFlusiva, is 27 percent more effective at preventing flu in this age group than standard-dose vaccines, ...

The FDA’s approval of an mRNA flu shot presents a new, long-awaited option—and raises big questions about the future of flu ...

(The Hill) -- The Food and Drug Administration (FDA) late Wednesday approved the nation's first mRNA flu vaccine, manufactured by drugmaker Moderna. The agency approved the shot for two age groups: ...

Key Takeaway: The FDA’s approval of mFLUSIVA may indicate increased commercial and strategic value of mRNA vaccine patents. On August 5, 2026, Moderna announced that the U.S. Food and Drug ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The U.S. Food and Drug Administration has approved a new flu vaccine, Moderna's mFlusiva, marking the public release of the first non-COVID-related mRNA vaccine in the U.S. Moderna's vaccine was ...

Despite significant drama from Trump officials this year, the Food and Drug Administration has for the first time approved a flu vaccine that uses mRNA technology. On Thursday, vaccine maker Moderna ...

Vice-prime minister and Public Health and Social Affairs minister Frank Vandenbroucke (R) is vaccinated during a vaccination campaign against the flu, at the AZ Jan Palfijn hospital, in Gent, on ...

Moderna’s new mRNA flu vaccine has been approved by the FDA for adults ages 50 years and older. FatCamera, E+/Getty ImagesThis article originally appeared onMedical News Today The FDA approved the ...

For some older adults, the flu vaccine could look a little different this year. In August, the U.S. Food and Drug ...